AmeriCann, Inc. (ACAN)
AmeriCann, Inc. operates in the Real Estate - Development industry of the Real Estate sector, headquartered in Denver, CO, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $4,878. On trailing twelve-month figures it carries a trailing P/E of -0.00, a net margin of -98.4%. Its beta of 0.06 implies it has historically moved less than the broad market.
AmeriCann, Inc., with its headquarters in Denver, Colorado, functions as a specialized cannabis enterprise throughout the United States. The company offers a complete range of services to authorized cannabis businesses, handling the conception, construction, leasing, and daily management of facilities crucial for cultivating, processing, and manufacturing cannabis products. A significant venture for the firm is the Massachusetts Cannabis Center, an extensive development located on a 52-acre property in Freetown, southeastern Massachusetts. Furthermore, AmeriCann supplies cannabis for both medical applications and adult recreational consumption. Incorporated in 2010, the organization initially operated as Nevada Health Scan, Inc., eventually rebranding to AmeriCann, Inc. in 2014.
AmeriCann, Inc. is most often compared with the following Real Estate names: